Clinical Trial

Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge

Study acronym: ETH47-201
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Phase IIa trial in participants with asthma to evaluate the impact of intranasal ETH47 on the development of asthma-related symptoms following rhinovirus challenge
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-08; most recent amendment 2026-06-25.
Trial Details
NCT Number NCT07059767
Lead Sponsor Ethris GmbH
Collaborators: VirTus Respiratory Research Ltd
Conditions Asthma (Diagnosis)
Enrollment 50 participants
Start Date 2025-06-24
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-26